Diagnosis of Tuberculosis in Swiss Children

RecruitingOBSERVATIONAL
Enrollment

190

Participants

Timeline

Start Date

May 12, 2017

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions
TuberculosisMycobacterium Tuberculosis
Interventions
DIAGNOSTIC_TEST

Secreted cytokine assay

Blood collected in a sodium-heparin tube will be used for the assay using novel TB-specific antigens. After incubation the supernatant will be harvested and cryopreserved at -80 °C for further testing of cytokines. Cytokines will be measured using a bead-based multiplex assay reader (MAGPIX, Luminex Crop., Austin, USA).

DIAGNOSTIC_TEST

Intracellular cytokine assay

Blood will be stimulated with recombinant MTB-specific antigens, ESAT-6, CFP-10, positive control or left unstimulated. Following an initial duration of stimulation, Brefeldin-A will be added and the blood incubated for a further 5 hours. White cells will be fixed and cryopreserved at - 80°. Batched analysis within 6 months of cryopreservation will be done using multi-colour flow cytometry.

Trial Locations (8)

1205

RECRUITING

Hôpital des enfants - HUG, Geneva

3010

RECRUITING

Inselspital Bern, Bern

4056

RECRUITING

Nina Vaezipour, Basel

5001

RECRUITING

Kantonspital Aarau, Aarau

6016

RECRUITING

Kinserspital Luzern, Lucerne

6500

RECRUITING

Ospedale Regionale di Bellinzona, Bellinzona

8032

RECRUITING

Kinderklinik Zürich, Zurich

9006

RECRUITING

Kinderspital St Gallen, Sankt Gallen

All Listed Sponsors
collaborator

Ospedale Regionale Bellinzona e Valli

OTHER

collaborator

Insel Gruppe AG, University Hospital Bern

OTHER

collaborator

University of Lausanne Hospitals

OTHER

collaborator

University Hospital, Geneva

OTHER

collaborator

Luzerner Kantonsspital

OTHER

collaborator

Cantonal Hospital of St. Gallen

OTHER

collaborator

University Children's Hospital, Zurich

OTHER

collaborator

Kantonsspital Aarau

OTHER

lead

University Children's Hospital Basel

OTHER